Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2007
03/22/2007US20070066650 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne
03/22/2007US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis
03/22/2007US20070066626 Compounds, compositions and methods
03/22/2007US20070066623 Entry inhibitors of the hiv virus
03/22/2007US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors
03/22/2007US20070066606 Benzylbenzimidazolyl derivatives
03/22/2007US20070066596 Pesticidal 5-substituted-oxalkylamino-1-arylpyrazole derivatives
03/22/2007US20070066590 Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/22/2007US20070066584 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
03/22/2007US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
03/22/2007US20070066542 Novel imidazole derivatives, their preparation and their use as medicaments
03/22/2007CA2622571A1 Methods of modulating neurotrophin-mediated activity
03/22/2007CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
03/22/2007CA2622222A1 Therapeutic pyrrolidines
03/22/2007CA2621983A1 Azafused cyclin dependent kinase inhibitors
03/22/2007CA2621408A1 1,2-diarylimidazoles for use as cb1 modulators
03/22/2007CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
03/22/2007CA2619309A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
03/21/2007EP1764364A1 A method for the purification of lansoprazole
03/21/2007EP1764362A1 Biaryl derivatives
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1763524A1 Indole derivatives and use thereof as kinase inhibitors
03/21/2007EP1763523A1 Quinazolinedione derivatives as parp inhibitors
03/21/2007EP1763522A1 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
03/21/2007EP1763521A1 1- (indole-6-carbonyl-d-phenylglycinyl)-4- (l-methylpiperidin-4- yl) piperazine d-tartrate
03/21/2007EP1763518A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
03/21/2007EP1763517A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors
03/21/2007EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
03/21/2007EP1763350A1 Nicotinamide derivatives and their use as therapeutic agents
03/21/2007EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof
03/21/2007EP1763302A2 Chemical compounds
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
03/21/2007EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases
03/21/2007CN1934213A Material for organic electroluminescence device and organic electroluminescence device utilizing the same
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/21/2007CN1934099A N-piperidine derivates as CCR3 modulators
03/21/2007CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders
03/21/2007CN1934090A Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
03/21/2007CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/21/2007CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes
03/21/2007CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
03/21/2007CN1934082A Organic compounds
03/21/2007CN1934081A Novel benayl(idene)-lactam derivatives
03/21/2007CN1933839A Compounds and methods of use
03/21/2007CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5
03/21/2007CN1933836A Heteroaryl piperidine glycine transporter inhibitors
03/21/2007CN1933832A Ion channel modulators
03/21/2007CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors
03/21/2007CN1931839A Synthesis process of N-substituted pyrrole
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/21/2007CN1305858C Substituted azole compounds and their preparation and application
03/21/2007CN1305857C Insecticidal and acaricidal 3-substituted pyrazoles
03/21/2007CN1305852C Diaryl ethers as opioid receptor antagonist
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
03/21/2007CN1305475C Boronic ester and acid compounds, synthesis and uses
03/20/2007US7193080 Color photography
03/20/2007US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors
03/20/2007US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates
03/20/2007US7192977 Duocamycin prodrugs; binding to Dna
03/20/2007US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/20/2007US7192968 Ethylenediamine derivatives
03/20/2007US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192959 Sodium channel blockers
03/20/2007US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
03/20/2007US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192954 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
03/20/2007US7192953 Antibacterial agents
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/20/2007US7192949 Anticarcinogenic and antiproliferative agents
03/20/2007CA2297326C Heterocyclic compound and antitumor agent containing the same as active component
03/15/2007WO2007030377A1 Substituted benzimidazoles as kinase inhibitors
03/15/2007WO2007030080A1 Heterocyclic compounds
03/15/2007WO2007029847A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007WO2007029696A1 Electron transporting material and organic electroluminescent device using the same
03/15/2007WO2007029629A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
03/15/2007WO2007029587A1 β SECRETASE INHIBITOR
03/15/2007WO2007029078A2 Succinimide and glutarimide derivatives as adrenergic receptor antagonists
03/15/2007WO2007029076A1 Isoindole derivatives as antimicrobial agents
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007028849A1 Pyrazolecarboxamide derivatives, method of obtaining same and use thereof as inverse antagonists/agonists of the cannabinoid cb1 and opioid mu receptor
03/15/2007WO2007028445A1 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
03/15/2007WO2007016674A3 2-aminoaryl pyridines as protein kinases inhibitors
03/15/2007WO2007011417A3 Metallic chromonic compounds
03/15/2007WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
1 ... 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 ... 1080